Takeda Pharmaceutical Ownership | Who Owns Takeda Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

Takeda Pharmaceutical Ownership Summary


Takeda Pharmaceutical is owned by 2.11% institutional investors, 0.01% insiders, and 97.87% retail investors. Capital research global investors is the largest institutional shareholder, holding 0.83% of TAK shares. Capital Group American Mutual Comp is the top mutual fund, with 0.41% of its assets in Takeda Pharmaceutical shares.

TAK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTakeda Pharmaceutical2.11%0.01%97.87%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.69%10.91%62.39%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capital research global investors13.16M0.83%$174.27M
Morgan stanley4.99M0.32%$64.53M
Goldman sachs group4.63M0.29%$61.28M
Arrowstreet capital, limited partnership4.22M0.27%$55.82M
Fmr3.39M0.21%$44.83M
First trust advisors lp3.24M0.20%$42.91M
Renaissance3.08M0.19%$40.77M
Brandes investment partners, lp3.04M0.19%$40.24M
Van eck associates2.21M0.14%$29.27M
Blackrock funding, inc. /de2.20M0.14%$29.18M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Managed asset portfolios1.42M2.78%$18.77M
Clean yield group360.09K1.52%$4.77M
Xy capital162.70K1.04%$2.15M
Soleus capital management1.18M0.98%$15.62M
Summit global investments729.20K0.60%$9.65M
Legacy wealth asset management140.84K0.51%$1.86M
Causeway capital management1.35M0.48%$17.52M
Gold investment management82.15K0.46%$1.09M
Brandes investment partners, lp3.04M0.45%$40.24M
Cowen and company530.60K0.19%$6.87M

Top Buyers

HolderShares% AssetsChange
Ubs group1.66M0.00%1.59M
Soleus capital management1.18M0.98%680.00K
Cowen and company530.60K0.19%530.60K
Toronto dominion bank510.60K0.01%510.60K
Bnp paribas arbitrage, snc500.68K0.00%497.46K

Top Sellers

HolderShares% AssetsChange
Mondrian investment partners1.54K0.00%-5.09M
Millennium management2.00M0.01%-1.41M
Bank of america corp /de/867.06K0.00%-616.95K
Blackrock1.44M0.00%-558.24K
Envestnet asset management984.68K0.00%-460.84K

New Positions

HolderShares% AssetsChangeValue
Cowen and company530.60K0.19%530.60K$6.87M
Toronto dominion bank510.60K0.01%510.60K$6.76M
Cubist systematic strategies446.76K0.04%446.76K$5.92M
Lmr partners llp230.00K0.03%230.00K$3.05M
Balyasny asset management193.20K0.00%193.20K$2.56M

Sold Out

HolderChange
Northwest financial advisors-1.00
Transamerica financial advisors-1.00
West branch capital-3.00
Ameritas investment partners-15.00
Sugarloaf wealth management-15.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024182-40.13%33,476,783-56.07%29.19%84-48.47%58-31.76%
Sep 30, 20243015.24%76,190,3605.65%423.28%16033.33%85-16.67%
Jun 30, 2024285-10.94%72,112,827-7.86%418.47%120-25.93%10121.69%
Mar 31, 20243202.56%78,262,422-6.37%417.57%16240.87%83-33.60%
Dec 31, 2023312-1.58%83,587,8173.95%579.64%115-21.77%12534.41%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Capital Group American Mutual Comp12.94M0.41%-
American Funds American Mutual A12.94M0.41%-
First Trust Value Line® Dividend ETF2.72M0.09%-
VanEck Pharmaceutical ETF2.05M0.06%-
Mondrian Int Eq Delivered Strategy816.00K0.03%-1.77M
MAP Global Equity Composite682.50K0.02%-24.46K
MAP Global Balanced Composite380.65K0.01%-140.35K
ActivePassive International Equity ETF338.51K0.01%-
Avantis International Equity ETF293.51K0.01%-
MAP Global Equity Ex-Options Composite274.11K0.01%-16.14K

Insider Transactions Trends


DateBuySell
2022 Q4--

TAK Ownership FAQ


Who Owns Takeda Pharmaceutical?

Takeda Pharmaceutical shareholders are primarily institutional investors at 2.11%, followed by 0.01% insiders and 97.88% retail investors. The average institutional ownership in Takeda Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.69%, which Takeda Pharmaceutical falls below.

Who owns the most shares of Takeda Pharmaceutical?

Takeda Pharmaceutical’s largest shareholders are Capital research global investors (13.16M shares, 0.83%), Morgan stanley (4.99M shares, 0.32%), and Goldman sachs group (4.63M shares, 0.29%). Together, they hold 1.44% of Takeda Pharmaceutical’s total shares outstanding.

Does Blackrock own Takeda Pharmaceutical?

BlackRock is not among the top 10 institutional shareholders of Takeda Pharmaceutical.

Who is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Managed asset portfolios is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 2.78% of its assets in 1.42M Takeda Pharmaceutical shares, valued at 18.77M$.

Who is the top mutual fund holder of Takeda Pharmaceutical shares?

Capital Group American Mutual Comp is the top mutual fund holder of Takeda Pharmaceutical shares, with 0.41% of its total shares outstanding invested in 12.94M Takeda Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools